Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy

Cancer Research

Volumn 61, Issue 6, 2001, Pages 2413-2419

  Geng, Ling ^a   Donnelly, Edwin ^a   McMahon, Gerald ^c   Lin, P Charles ^a   Sierra Rivera, Elaine ^a   Oshinka, Halina ^a   Hallahan, Dennis E ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c SUGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [(4,5 DIMETHYL 1H PYRROL 2 YL)METHYLENE] 1,3 DIHYDRO 2H INDOL 2 ONE; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GLIOBLASTOMA; IN VIVO STUDY; MELANOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TREATMENT FAILURE; TUMOR RESISTANCE; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GLIOBLASTOMA; INDOLES; LYMPHOKINES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; PYRROLES; RADIATION TOLERANCE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035866771     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Vascularity and blood flow in x-irradiated Walker carcinoma 256 of rats
2. Sarcoma blood perfusion change after X-irradiation
3. Radiation effect on the proliferating capillaries in rat transparent chambers
4. Blood flow in irradiated mouse sarcoma as determined by the clearance of xenon-133
5. Microvasculature of C3H/Bi mouse mammary tumors after x-irradiation
6. A thermodynamic method for investigation of radiation induced changes in the microcirculation of human tumors
7. Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation
8. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis
9. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors
10. Brain tumors in children
11. Patterns of failure for GBM
12. Randomized comparison of treatment for malignant gliomas
13. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiform
14. Intratumoral heterogeneity of malignant gliomas measured in vitro
15. Enchancement of replication of genetically engineered herpes simplex virus by ionizing radiation: A new paradigm for destruction of intractable tumors
16. Radiation sensitizing gene therapy for malignant glioma xenografts
17. Response of xenografts of human malignant gliomas and squamous cell carcinomas to fractionated irradiation
18. Characterization of angiogenesis and microcirculation of high-grade glioma: An intravital multifluorescence microscopic approach in the athymic nude mouse
19. Tumor angiogenesis: A quantitative method for histological gradin
20. High affinity VEGF binding and development expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
21. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
22. Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy
23. Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor
24. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice
25. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rat
26. Specificity of vascular endothelial cell growth factor receptor ligand binding domains
27. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR
28. X-ray induced expression of P-selectin in tumor blood vessels
29. Spatial and temporal control of gene therapy by ionizing radiation
30. Use of ranks in one-criteria variance analysis
31. SU5416 is a potent and selective inhibitor of the VEFG receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types
32. Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis
33. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma
34. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
35. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms
36. Development of the vascular system in the hamster malignant neurilemmoma
37. Heterogeneity in tumor microvascular response to radiation
38. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cell
39. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression